Delivery Order SPE2DB22D1017-SPE2DB25FE8YR

Award Date 11/12/24
Potential Completion Date 11/13/24
Potential Value $3.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, with an ID of SPE2DB20D1100|SPE2DB25FZ18M, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,030.14 firm fixed-price delivery order is for the supply of OPZELURA 1.5% Cream, a pharmaceutical product, with a completion date of November 22, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award, with ID SPE2DB22D3004|SPE2DB24FPK03, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of OPZELURA 1.5% cream, a pharmaceutical product, with a ceiling value of $2,578.87 and a completion date of February 21, 2024. The contract is a Delivery Order under a Firm Fixed Price pricing type. This award is not designated as a set-aside...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of OPZELURA 1.5% Cream, a pharmaceutical product, with a ceiling value of $9,076.42 and a completion date of June 10, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,164.79 firm-fixed-price delivery order is for the supply of OPZELURA 1.5% cream, a pharmaceutical product, with a completion date of July 19, 2024. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp is the prime contractor and holds a $999,999,999 Indefinite Delivery Contract (IDC) with...
This federal contract award, valued at $10,319.11, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of OPZELURA 1.5% CREAM 60GM, a medical product, with a completion date of May 19, 2025. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,757.38 firm fixed-price delivery order is for the supply of OPZELURA 1.5% Cream in 60-gram sizes. The contract has an ultimate completion date of March 26, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $19,275.47 and a completion date of December 10, 2024. It is a firm fixed-price contract for the delivery of OPZELURA 1.5% Cream, a pharmaceutical product. The contract is not set aside for any specific business designation. AmerisourceBergen holds a significant Indefinite Delivery...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The contract, valued at $17,293.59, is for the delivery of OPZELURA 1.5% Cream in 60 gram packaging. The order is a firm fixed-price contract with a completion date of July 17, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of OPZELURA 1.5% Cream, a pharmaceutical product, with a ceiling value of $1,539.12 and a completion date of April 1, 2024. This contract is a firm fixed-price delivery order, with no set-aside requirements. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
This federal contract award, with ID SPE2DB20D3103|SPE2DB24FP7B3, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,634.68, is for the delivery of OPZELURA 1.5% CREAM 60GM, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an Ultimate Completion Date of July 31, 2024. The contract was awarded on July 30, 2024 and...
  • SPE2DB22D1017
    Indefinite Delivery Contract
  • SPE2DB22D1017-SPE2DB25FE8YR
    Delivery Order

This federal contract award, with an ID of SPE2DB22D1017|SPE2DB25FE8YR, was issued by the Defense Logistics Agency (DLA) to the prime contractor, AmerisourceBergen Drug Corp. The contract is for the delivery of OPZELURA 1.5% Cream, a pharmaceutical product, with a ceiling value of $3,214.71 and a completion date of November 13, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal government agencies. The company holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 5/20/25, 2:23 PM